Literature DB >> 10335545

Lack of genetic linkage or association between a functional serotonin transporter polymorphism and panic disorder.

S P Hamilton1, G A Heiman, F Haghighi, S Mick, D F Klein, S E Hodge, M M Weissman, A J Fyer, J A Knowles.   

Abstract

Given the efficacy of medications that interact with the serotonin transporter (5-HTT) in the treatment of panic disorder, we have used a family-based design to test for genetic association and linkage between panic disorder and a functional polymorphism in the promoter of the gene for 5-HTT. In this study, 340 individuals in 45 families, as well as 74 haplotype relative risk 'trios' were genotyped at the polymorphic locus, which consists of a 44 base pair deletion/insertion. There were no significant differences in allele frequencies or occurrence of genotypes within the triads. No linkage between the 5-HTT polymorphism and panic disorder was observed in the multiplex families, using a variety of simulations for dominant and recessive models of inheritance. Recent reports suggest an association between the 5-HTT polymorphism and anxiety-related traits, as measured with personality assessment. The results reported here provide evidence that the genetic basis of panic disorder may be distinct from anxiety-related traits assessed by personality inventories in normal populations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10335545     DOI: 10.1097/00041444-199903000-00001

Source DB:  PubMed          Journal:  Psychiatr Genet        ISSN: 0955-8829            Impact factor:   2.458


  15 in total

1.  Evidence for linkage and association of GABRB3 and GABRA5 to panic disorder.

Authors:  Laura M Hodges; Abby J Fyer; Myrna M Weissman; Mark W Logue; Fatemeh Haghighi; Oleg Evgrafov; Allessandro Rotondo; James A Knowles; Steven P Hamilton
Journal:  Neuropsychopharmacology       Date:  2014-05-23       Impact factor: 7.853

Review 2.  Genetic animal models of anxiety.

Authors:  Deborah A Finn; Mark T Rutledge-Gorman; John C Crabbe
Journal:  Neurogenetics       Date:  2003-03-29       Impact factor: 2.660

3.  Determinants of pharmacodynamic trajectory of the therapeutic response to paroxetine in Japanese patients with panic disorder.

Authors:  Shin Ishiguro; Takashi Watanabe; Mikito Ueda; Yoshinori Saeki; Yuki Hayashi; Kazufumi Akiyama; Atsushi Saito; Kazuko Kato; Yoshimasa Inoue; Kazutaka Shimoda
Journal:  Eur J Clin Pharmacol       Date:  2011-06-19       Impact factor: 2.953

4.  Elevated tph2 mRNA expression in a rat model of chronic anxiety.

Authors:  Nina C Donner; Philip L Johnson; Stephanie D Fitz; Karen E Kellen; Anantha Shekhar; Christopher A Lowry
Journal:  Depress Anxiety       Date:  2012-04       Impact factor: 6.505

5.  Further genetic evidence for a panic disorder syndrome mapping to chromosome 13q.

Authors:  Steven P Hamilton; Abby J Fyer; Martina Durner; Gary A Heiman; Ada Baisre de Leon; Susan E Hodge; James A Knowles; Myrna M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

6.  Association of a polyadenylation polymorphism in the serotonin transporter and panic disorder.

Authors:  Sandeep Gyawali; Ryan Subaran; Myrna M Weissman; Dylan Hershkowitz; Morgan C McKenna; Ardesheer Talati; Abby J Fyer; Priya Wickramaratne; Phillip B Adams; Susan E Hodge; Carl J Schmidt; Michael J Bannon; Charles E Glatt
Journal:  Biol Psychiatry       Date:  2009-12-06       Impact factor: 13.382

Review 7.  The serotonergic system and anxiety.

Authors:  Joshua A Gordon; Rene Hen
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

8.  Association of Anxiety Symptoms in Offspring of Bipolar Parents with Serotonin Transporter-Linked Polymorphic Region (5-HTTLPR) Genotype.

Authors:  Min-Hyeon Park; Erica Sanders; Meghan Howe; Manpreet Singh; Joachim Hallmayer; Eunjoo Kim; Kiki Chang
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-07-28       Impact factor: 2.576

9.  The serotonin transporter genotype is associated with intermediate brain phenotypes that depend on the context of eliciting stressor.

Authors:  N H Kalin; S E Shelton; A S Fox; J Rogers; T R Oakes; R J Davidson
Journal:  Mol Psychiatry       Date:  2008-04-15       Impact factor: 15.992

10.  Genetic and pharmacokinetic factors affecting the initial pharmacotherapeutic effect of paroxetine in Japanese patients with panic disorder.

Authors:  Yoshinori Saeki; Takashi Watanabe; Mikito Ueda; Atsushi Saito; Kazufumi Akiyama; Yoshimasa Inoue; Genta Hirokane; Sachiyo Morita; Naoto Yamada; Kazutaka Shimoda
Journal:  Eur J Clin Pharmacol       Date:  2009-03-04       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.